Skip to content

Clinical trials

Phase 2 Inflammatory Bowel Diseases trials in the Netherlands

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Inflammatory Bowel Diseases Phase: Phase 2 Country / region: Netherlands Clear all

12 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20113
20151
20163
20213
20231
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed7
Terminated3
Recruiting2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Amgen2
Applied Molecular Transport2
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)1
AstraZeneca1
Bristol-Myers Squibb1
Dalia Lartey1
Eli Lilly and Company1
Protagonist Therapeutics, Inc.1
Toray Industries, Inc1
University Medical Center Groningen1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Inflammatory Bowel Diseases12
Colitis, Ulcerative6
Crohn Disease6
Arthritis, Rheumatoid1
Inflammation1
Irritable Bowel Syndrome1
Pouchitis1

Trials

Showing 1 to 12 of 12. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.